# Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients

> **NCT00151801** · PHASE2 · UNKNOWN · sponsor: **S. Andrea Hospital** · enrollment: 200 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** estroprogestins
- **DRUG:** interferon-beta 1a

## Key facts

- **NCT ID:** NCT00151801
- **Lead sponsor:** S. Andrea Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-05
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 200 (—)
- **Last updated:** 2005-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151801, "Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00151801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*